Cargando…
Histone deacetylase 6 expression in metastatic lymph nodes is a valuable prognostic marker for resected node-positive esophageal squamous cell cancer
BACKGROUND: Histone deacetylase 6 (HDAC6) exerts enzymatic deacetylation activity on histones and on non-histone substrates and plays a key role in microtubule dynamics and chaperone activities. In addition, previous studies have demonstrated its role in cancer progression. However, its clinical sig...
Autores principales: | Xie, Xuan, Luo, Kongjia, Li, Yi, Ling, Yihong, Zhang, Shuishen, Xie, Xiuying, Wen, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234999/ https://www.ncbi.nlm.nih.gov/pubmed/30519093 http://dx.doi.org/10.2147/CMAR.S178575 |
Ejemplares similares
-
miR-424 coordinates multilayered regulation of cell cycle progression to promote esophageal squamous cell carcinoma cell proliferation
por: Wen, Jing, et al.
Publicado: (2018) -
Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study
por: Li, Kexun, et al.
Publicado: (2023) -
Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes
por: Leslie, Patrick L., et al.
Publicado: (2019) -
Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
por: Fang, Shuogui, et al.
Publicado: (2022) -
The epithelial-mesenchymal transition phenotype of metastatic lymph nodes impacts the prognosis of esophageal squamous cell carcinoma patients
por: Wen, Jing, et al.
Publicado: (2016)